IX Biopharma Discloses Result of IXB 401 Preclinical Study

MT Newswires11/20 07:45

IX Biopharma Schedules Extraordinary General Meeting for Scheme Extensions

MT Newswires10/01 10:52

財務諸表および関連発表-会計監査人のコメント

SGX09/30 22:52

IX Biopharma Advances Wafermine Out-Licensing, Starts Preclinical Trials for IXB 401

MT Newswires09/17 10:41

New Study Demonstrates That SL-NAD+ Delivers NAD+ Into Cells

PR Newswire09/02 09:00

IX Biopharma Widens Net Loss by 12% in FY2024

Singapore Business Review08/27 16:51